JCI - Citations to Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Citations to this article

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

A Vitiello, … , J Furze, R Bartholomeuz

A Vitiello, … , J Furze, R Bartholomeuz

Published January 1, 1995
Citation Information: J Clin Invest. 1995;95(1):341-349. https://doi.org/10.1172/JCI117662.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2022	2021	2020	2018	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1991	1961	Total
Citations:	1	2	3	2	1	4	7	6	4	4	5	11	9	6	7	5	12	3	14	15	21	20	19	16	28	17	7	1	1	1	252

Citation information

Citations to this article (252)

Title and authors	Publication	Year
Functional Cure for Hepatitis B Virus: Challenges and Achievements Shechter O, Sausen DG, Dahari H, Vaillant A, Cotler SJ, Borenstein R	International Journal of Molecular Sciences	2025
Immune therapies against chronic hepatitis B. Akbar SMF, Yoshida O, Hiasa Y	Journal of Gastroenterology	2022
Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection. Akbar SMF, Mahtab MA, Khan S, Yoshida O, Hiasa Y	Human vaccines	2022
Therapeutic vaccination for treatment of chronic hepatitis B T Cargill, E Barnes	Clinical & Experimental Immunology	2021
Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures DT Jansen, Y Dou, JW de Wilde, AM Woltman, SI Buschow	IBMS BoneKEy	2021
CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy SI Buschow, DT Jansen	Cells	2021
Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery S Bartlett, M Skwarczynski, I Toth	Current medicinal chemistry	2020
Cytosolic delivery of HBsAg and enhanced cellular immunity by pH-responsive liposome F Hu, H Yue, T Lu, G Ma	Journal of Controlled Release	2020
Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant Z Zhou, H Lin, C Li, Z Wu	Chinese Chemical Letters	2018
A second chance for telomerase reverse transcriptase in anticancer immunotherapy M Zanetti	Nature Reviews Clinical Oncology	2016
Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice HW Kavunja, S Lang, S Sungsuwan, Z Yin, X Huang	Cancer Immunology, Immunotherapy	2016
Advances in Antiviral Therapies Targeting Toll-like Receptors M Shah, MA Anwar, JH Kim, S Choi	Expert Opinion on Investigational Drugs	2016
Immunostimulation by phospholipopeptide biosurfactant from Staphylococcus hominis in Oreochromis mossambicus V Rajeswari, SK Priyadarshini, V Saranya, P Suguna, R Shenbagarathai	Fish & Shellfish Immunology	2016
Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact KY Shen, LS Chang, CH Leng, SJ Liu	Expert Review of Vaccines	2015
Lipopeptides: from self-assembly to bioactivity IW Hamley	Chemical Communications	2015
Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients S Bellone, F Centritto, J Black, C Schwab, D English, E Cocco, S Lopez, E Bonazzoli, F Predolini, F Ferrari, DA Silasi, E Ratner, M Azodi, PE Schwartz, AD Santin	Gynecologic Oncology	2015
TLR ligand induced IL-6 counter-regulates the anti-viral CD8+ T cell response during an acute retrovirus infection W Wu, KK Dietze, K Gibbert, KS Lang, M Trilling, H Yan, J Wu, D Yang, M Lu, M Roggendorf, U Dittmer, J Liu	Scientific Reports	2015
Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand A Weinstock, M Pevsner-Fischer, Z Porat, M Selitrennik, D Zipori	Stem Cell Reviews and Reports	2015
Hepatitis B virus therapy: What’s the future holding for us? S Manzoor	World journal of gastroenterology : WJG	2015
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions GM Graziani, JB Angel	Journal of the International AIDS Society	2015
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands D Toussi, P Massari	Human vaccines	2014
Molecular Mechanisms of TLR2-Mediated Antigen Cross-Presentation in Dendritic Cells KY Shen, YC Song, IH Chen, CH Leng, HW Chen, HJ Li, P Chong, SJ Liu	Journal of immunology (Baltimore, Md. : 1950)	2014
MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection JD Comber, A Karabudak, V Shetty, JS Testa, X Huang, R Philip	Hepatitis Research and Treatment	2014
Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates CC Fraser, DH Altreuter, P Ilyinskii, L Pittet, RA LaMothe, M Keegan, L Johnston, TK Kishimoto	Vaccine	2014
Tracking Targeted Bimodal Nanovaccines: Immune Responses and Routing in Cells, Tissue, and Whole Organism LJ Cruz, PJ Tacken, IS Zeelenberg, M Srinivas, F Bonetto, B Weigelin, C Eich, IJ de Vries, CG Figdor	Molecular Pharmaceutics	2014
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection E Zhang, M Lu	Medical Microbiology and Immunology	2014
Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships M Zaman, I Toth	Frontiers in immunology	2013
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice P Buchmann, C Dembek, L Kuklick, C Jäger, R Tedjokusumo, MJ von Freyend, U Drebber, Z Janowicz, K Melber, U Protzer	Vaccine	2013
Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16) O Launay, M Surenaud, C Desaint, NB Hamouda, G Pialoux, B Bonnet, I Poizot-Martin, G Gonzales, L Cuzin, I Bourgault-Villada, Y Lévy, J Choppin, C Durier	Vaccine	2013
Vaccines RW Sutter, OM Kew, SL Cochi, RB Aylward	Human vaccines	2013
Design of therapeutic vaccines: hepatitis B as an example S Kutscher, T Bauer, C Dembek, M Sprinzl, U Protzer	Microbial Biotechnology	2012
Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications JS Testa, R Philip	Future Virology	2012
Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections AA Chentoufi, L Benmohamed	Clinical & developmental immunology	2012
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant CL Rosa, J Longmate, SF Lacey, T Kaltcheva, R Sharan, D Marsano, P Kwon, J Drake, B Williams, S Denison, S Broyer, L Couture, R Nakamura, S Dadwal, MI Kelsey, AM Krieg, DJ Diamond, JA Zaia	The Journal of Infectious Diseases	2012
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose T Lövgren, P Baumgaertner, S Wieckowski, E Devêvre, P Guillaume, I Luescher, N Rufer, DE Speiser	Cancer Immunology Immunotherapy	2011
HBV life cycle and novel drug targets D Grimm, R Thimme, HE Blum	Hepatology International	2011
Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells LJ Cruz, PJ Tacken, F Bonetto, SI Buschow, HJ Croes, M Wijers, IJ de Vries, CG Figdor	Molecular Pharmaceutics	2011
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells LJ Cruz, PJ Tacken, R Fokkink, CG Figdor	Biomaterials	2011
Advances in Immunology E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné	Advances in Immunology Volume 110	2011
Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity S Wang, R Buchli, J Schiller, J Gao, RS VanGundy, WH Hildebrand, DD Eckels	World journal of gastroenterology : WJG	2010
Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck AD Kosinska, E Zhang, M Lu, M Roggendorf	Hepatitis Research and Treatment	2010
TLR-Based Immune Adjuvants F Steinhagen, T Kinjo, C Bode, DM Klinman	Vaccine	2010
Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers J Luo, J Li, RL Chen, L Nie, J Huang, ZW Liu, L Luo, XJ Yan	Vaccine	2010
Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice L Ochoa-Callejero, I Otano, A Vales, C Olagüe, P Sarobe, JJ Lasarte, J Prieto, S Menne, G González-Aseguinolaza	Vaccine	2010
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro LJ Cruz, PJ Tacken, R Fokkink, B Joosten, MC Stuart, F Albericio, R Torensma, CG Figdor	Journal of Controlled Release	2010
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys W Zeng, E Eriksson, B Chua, L Grollo, DC Jackson	Amino Acids	2010
Topley & Wilson's Microbiology and Microbial Infections TG Harrison	Topley & Wilson's Microbiology and Microbial Infections	2010
Hepatitis B virus surface antigen can activate dendritic cells and modulate T helper type immune response: HBsAg can modulate Th type immune response RH Jan, YL Lin, LK Chen, MT Huang, LC Wang, BL Chiang	Microbiology and Immunology	2010
Clinical Hepatology H Dancygier		2010
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures BR Minev		2010
Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies Y Kondo, Y Ueno, T Shimosegawa	Clinical Journal of Gastroenterology	2009
A novel mouse model for immunogenic evaluation of human HBV vaccines Y Guo, D Ren, X He, F Wang, L Jiang, S Song, Y He, S Sun	Vaccine	2009
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes LE Brown, A Kelso	Immunology and Cell Biology	2009
Therapeutic vaccination and novel strategies to treat chronic HBV infection A Bertoletti, A Gehring	Expert Review of Gastroenterology & Hepatology	2009
A review of multiple approaches towards an improved hepatitis B vaccine G Sanyal, L Shi	Expert Opinion on Therapeutic Patents	2009
New Generation Vaccines, Fourth Edition A Loukas, J Bethony, A Capron, D McManus	New Generation Vaccines, Fourth Edition	2009
Principles of Cancer Biotherapy RK Oldham, RO Dillman		2009
Drug targets in hepatitis B virus infection Lance L Stein, Rohit Loomba	Infectious disorders drug targets	2009
Drug Targets in Hepatitis B Virus Infection Stein LL, Loomba R	Infectious disorders drug targets	2009
The Molecular Basis of Cancer A Bafico, L Grumolato, SA Aaronson	The Molecular Basis of Cancer	2008
Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors KL Jones, LE Brown, EM Eriksson, RA Ffrench, PA Latour, BE Loveland, DM Wall, SK Roberts, DC Jackson, EJ Gowans	Journal of Viral Hepatitis	2008
Molecular therapy and prevention of liver diseases HE Blum	Virologica Sinica	2008
Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines I Toth, P Simerska, Y Fujita	International Journal of Peptide Research and Therapeutics	2008
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults GJ Gorse, LR Baden, M Wecker, MJ Newman, G Ferrari, KJ Weinhold, BD Livingston, TL Villafana, H Li, E Noonan, ND Russell	Vaccine	2008
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates Y Fujita, AB Abdel-Aal, N Wimmer, MR Batzloff, MF Good, I Toth	Bioorganic & Medicinal Chemistry	2008
Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques DH Fuller, T Shipley, TM Allen, JT Fuller, MS Wu, H Horton, N Wilson, G Widera, DI Watkins	Virology	2007
Vaccines and immunotherapies against hepatitis B and hepatitis C viruses G Inchauspé, ML Michel	Journal of Viral Hepatitis	2007
Viral peptide immunogens: current challenges and opportunities A Azizi, F Diaz-Mitoma	Journal of Peptide Science	2007
Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation J PENG, Y ZHAO, J MAI, W PANG, W GUO, G CHEN, G MO, G RAO, Y XU	Acta Pharmacologica Sinica	2007
Mass spectrometry and peptide-based vaccine development IG Ovsyannikova, KL Johnson, HR 3rd, GA Poland	Clinical Pharmacology & Therapeutics	2007
Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial O Launay, C Durier, C Desaint, B Silbermann, A Jackson, G Pialoux, B Bonnet, I Poizot-Martin, G Gonzalez-Canali, L Cuzin, S Figuereido, M Surenaud, NB Hamouda, H Gahery, J Choppin, D Salmon, C Guérin, IB Villada, JG Guillet, J Campbell	PloS one	2007
Genetics in Liver Diseases HE Blum, D Häussinger, DW Cox, PL Jansen, GA Kullak-Ublick		2007
Translational Medicine JV Tricoli	Prostate Cancer: Translational and Emerging Therapies	2006
Therapeutic vaccination in chronic hepatitis B virus carriers S Pol, ML Michel	Expert Review of Vaccines	2006
Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects A Pajot, ML Michel, M Mancini-Bourgine, MN Ungeheuer, DM Ojcius, Q Deng, FA Lemonnier, YC Lone	Microbes and Infection	2006
Colorectal Cancer G Chong, D Cunningham	Colorectal Cancer	2006
Disease Progression and Disease Prevention in Hepatology and Gastroenterology PR Galle, WE Schmidt, G Gerken, B Wiedenmann		2006
Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct A Roth, F Rohrbach, R Weth, B Frisch, F Schuber, WS Wels	British Journal of Cancer	2005
Immunomodulatory therapy for chronic hepatitis B virus infection D Sprengers, HL Janssen	Fundamental and Clinical Pharmacology	2005
Novel conjugates of epitope fusion peptides with CpG-ODN display enhanced immunogenicity and HIV recognition P Daftarian, R Sharan, W Haq, S Ali, J Longmate, J Termini, DJ Diamond	Vaccine	2005
Synthetic bacterial lipopeptide analogs: structural requirements for adjuvanticity M Ghielmetti, A Reschner, M Zwicker, E Padovan	Immunobiology	2005
Synthetic bacterial lipopeptide analogs facilitate naive CD4+ T cell differentiation and enhance antigen-specific HLA-II-restricted responses M Ghielmetti, M Zwicker, T Ghielmetti, MM Simon, PM Villiger, E Padovan	European Journal of Immunology	2005
Therapeutic vaccination against chronic hepatitis B virus infection ML Michel, M Mancini-Bourgine	Journal of Clinical Virology	2005
Vaccination with recombinant HBsAg–HBIG complex in healthy adults DZ Xu, KL Huang, K Zhao, L Xu, N Shi, ZH Yuan, YM Wen	Vaccine	2005
In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus S Malmassari, YC Lone, M Zhang, C Transy, ML Michel	Microbes and Infection	2005
Traitement des infections chroniques dues au virus de l’hépatite B par vaccination thérapeutique M Mancini-Bourgine, ML Michel	Thérapie	2005
Lymphocyte Proliferation Responses Induced to Broadly Reactive Th Peptides Did Not Protect against Equine Infectious Anemia Virus Challenge DG Fraser, SR Leib, BS Zhang, RH Mealey, WC Brown, TC McGuire	Clinical and vaccine immunology : CVI	2005
Effect of Glycoamphiphiles on the Solubilization and Dendritic Cell Uptake of a Lipopeptide: A Preliminary Study D Bonnet, G Angyalosi, A Demory, V Santraine, A Boulet, C Spriet, L Héliot, H Gras-Masse, C Grandjean	Molecular Pharmaceutics	2005
Development and Validation of a Fluorescence Polarization-Based Competitive Peptide-Binding Assay for HLA-A*0201A New Tool for Epitope Discovery R Buchli, RS VanGundy, HD Hickman-Miller, CF Giberson, W Bardet, WH Hildebrand	Biochemistry	2005
Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides B Langhans, I Braunschweiger, S Schweitzer, T Sauerbruch, U Spengler	Vaccine	2004
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling D Montagna, R Schiavo, N Gibelli, P Pedrazzoli, R Tonelli, S Pagani, E Assirelli, F Locatelli, A Pession, V Fregoni, E Montini, GA da Prada, S Siena, R Maccario	International Journal of Cancer	2004
Cellular Immune Responses to the Hepatitis B Virus Polymerase E Mizukoshi, J Sidney, B Livingston, M Ghany, JH Hoofnagle, A Sette, B Rehermann	Journal of immunology (Baltimore, Md. : 1950)	2004
Long-Term Specific Immune Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine: Characterization of CD8 + -T-Cell Epitopes Recognized H Gahéry-Ségard, G Pialoux, S Figueiredo, C Igéa, M Surenaud, J Gaston, H Gras-Masse, JP Lévy, JG Guillet	Journal of virology	2003
Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge P Daftarian, S Ali, R Sharan, SF Lacey, CL Rosa, J Longmate, C Buck, RF Siliciano, DJ Diamond	Journal of immunology (Baltimore, Md. : 1950)	2003
Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus MR Hilleman	Vaccine	2003
Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection B Dikici, M Bosnak, H Ucmak, A Dagli, A Ece, K Haspolat	Journal of Gastroenterology and Hepatology	2003
Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge SL Ridgely, B Zhang, TC McGuire	Vaccine	2003
Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design AW Purcell, W Zeng, NA Mifsud, LK Ely, WA Macdonald, DC Jackson	Journal of Peptide Science	2003
Mucosal immunogenicity of the hepatitis B core antigen Y Lobaina, D Garcı́a, N Abreu, V Muzio, JC Aguilar	Biochemical and Biophysical Research Communications	2003
Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes H Doh, S Roh, KW Lee, K Kim	FEMS Immunology & Medical Microbiology	2003
Translation of immunological knowledge into better treatments of chronic hepatitis B A Bertoletti, NV Naoumov	Journal of Hepatology	2003
Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection P Lebray, A Vallet-Pichard, ML Michel, H Fontaine, R Sobesky, C Bréchot, S Pol	Journal of Hepatology	2003
Tropical Diseases S Marzuki, J Verhoef, H Snippe		2003
Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses PA Sieling, W Chung, BT Duong, PJ Godowski, RL Modlin	Journal of immunology (Baltimore, Md. : 1950)	2003
Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells M Andrieu, JF Desoutter, E Loing, J Gaston, D Hanau, JG Guillet, A Hosmalin	Journal of virology	2003
Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides DG Fraser, RH Mealey, TC McGuire	Immunogenetics	2003
Immunology of hepatitis B infection MC Jung, GR Pape	The Lancet Infectious Diseases	2002
Therapeutic vaccination against chronic viral infections P Vandepapelière	The Lancet Infectious Diseases	2002
Towards immunotherapy for chronic hepatitis B virus infections ML Michel	Vaccine	2002
Evolving therapies for the treatment of chronic hepatitis B virus infection WE Delaney, A Bartholomeusz, SA Locarnini	Expert Opinion on Investigational Drugs	2002
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-γ ELISPOT assays CM Britten, RG Meyer, T Kreer, I Drexler, T Wölfel, W Herr	Journal of Immunological Methods	2002
Chronic Hepatitis B: Current and Future Treatment Options A Rivkina, S Rybalov	Pharmacotherapy	2002
Melanoma vaccines BR Minev	Seminars in Oncology	2002
Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses L BenMohamed, R Krishnan, C Auge, JF Primus, DJ Diamond	Immunology	2002
Immune downregulation leads to upregulation of an antiviral response: a lesson from the hepatitis B virus Y Ilan	Microbes and Infection	2002
A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo KY Lee, JH Yoon, M Kim, S Roh, YS Lee, BL Seong, K Kim	Biochemical and Biophysical Research Communications	2002
A new lipophilic fluorescent probe for interaction studies of bioactive lipopeptides with membrane models E Peroni, G Caminati, P Baglioni, F Nuti, M Chelli, AM Papini	Bioorganic & Medicinal Chemistry Letters	2002
Lipopeptide vaccines—yesterday, today, and tomorrow L BenMohamed, SL Wechsler, AB Nesburn	The Lancet Infectious Diseases	2002
Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge G Jung, DI Watkins, R Kurth, BE Beer, TU Vogel, HG Ihlenfeldt, J Megede, S Norley, JD Altman, S Holzammer	Journal of General Virology	2002
Cervical Cancer Vaccines: Progress and Prospects MA Steller	Journal of the Society for Gynecologic Investigation	2002
Induction of Long-Term Memory CD8 + T Cells for Recall of Viral Clearing Responses against Influenza Virus G Deliyannis, DC Jackson, NJ Ede, W Zeng, I Hourdakis, E Sakabetis, LE Brown	Journal of virology	2002
Immunotherapy for colorectal cancer KA Foon	Current Oncology Reports	2001
T-cell-directed cancer vaccines: the melanoma model E Wang, GQ Phan, FM Marincola	Expert Opinion on Biological Therapy	2001
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines BD Livingston, M Newman, C Crimi, D McKinney, R Chesnut, A Sette	Vaccine	2001
Development of a cytomegalovirus vaccine: lessons from recent clinical trials E Gonczol, S Plotkin	Expert Opinion on Biological Therapy	2001
Therapeutic efficacy of hepatitis B surface antigen–antibodies-recombinant DNA composite in HBsAg transgenic mice BJ Zheng, MH Ng, LF He, X Yao, KW Chan, KY Yuen, YM Wen	Vaccine	2001
Defined Synthetic Vaccines W Zauner, K Lingnau, F Mattner, A Gabain, M Buschle	Biological Chemistry	2001
Peptide vaccines against hepatitis B virus: from animal model to human studies OB Engler, WJ Dai, A Sette, IP Hunziker, J Reichen, WJ Pichler, A Cerny	Molecular Immunology	2001
Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future ML Michel, S Pol, C Brechot, P Tiollais	Vaccine	2001
Vaccines for Transplant Recipients DC Molrine, PL Hibberd	Infectious Disease Clinics of North America	2001
Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses S Roh, YK Lee, BY Ahn, K Kim, A Moon	Virus Research	2001
DNA Vaccination of Macaques with Several Different Nef Sequences Induces Multispecific T Cell Responses I Couillin, F Letourneur, P Lefèbvre, JG Guillet, F Martinon	Virology	2001
Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia Y Sobao, K Sugi, H Tomiyama, S Saito, S Fujiyama, M Morimoto, S Hasuike, H Tsubouchi, K Tanaka, M Takiguchi	Journal of Hepatology	2001
HEPATITIS B INFECTION IN CHINA GK Lau	Clinics in Liver Disease	2001
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study: CD8 + Response Induced by MART-Lipopeptides FA Gal, A Prevost-Blondel, R Lengagne, M Bossus, F Farace, A Chaboissier, H Gras-Masse, VH Engelhard, JG Guillet, H Gahéry-Ségard	International Journal of Cancer	2001
Technologies for the design, discovery, formulation and administration of vaccines RW Ellis	Vaccine	2001
Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations H Gras-Masse	Molecular Immunology	2001
In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein KJ Stittelaar, P Hoogerhout, W Ovaa, RR van Binnendijk, MC Poelen, P Roholl, CA van Els, AD Osterhaus, EJ Wiertz	Vaccine	2001
Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries CL Rosa, R Krishnan, S Markel, JP Schneck, R Houghten, C Pinilla, DJ Diamond	Blood	2001
CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice E Malanchère-Brès, PJ Payette, M Mancini, P Tiollais, HL Davis, ML Michel	Journal of virology	2001
Palmitoyl Derivatives of GpMBP Epitopes: T-Cell Response and Peptidases Susceptibility AM Papini, B Mazzanti, E Nardi, E Traggiai, C Ballerini, T Biagioli, H Kalbacher, H Beck, M Deeg, M Chelli, M Ginanneschi, L Massacesi, M Vergelli	Journal of Medicinal Chemistry	2001
Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy D Montagna, R Maccario, F Locatelli, V Rosti, Y Yang, P Farness, A Moretta, P Comoli, E Montini, A Vitiello	Blood	2001
Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection GK Lau	Journal of Gastroenterology and Hepatology	2000
Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8+ T lymphocyte activation M Andrieu, E Loing, JF Desoutter, F Connan, J Choppin, H Gras-Masse, D Hanau, A Dautry-Varsat, JG Guillet, A Hosmalin	European Journal of Immunology	2000
Evaluation of a Lipopeptide Immunogen as a Therapeutic in HIV Type 1-Seropositive Individuals A Seth, Y Yasutomi, H Jacoby, JC Callery, SM Kaminsky, WC Koff, DF Nixon, NL Letvin	AIDS Research and Human Retroviruses	2000
HLA in Health and Disease A Friedmann	HLA in Health and Disease	2000
Induction of CTL response by a minimal epitope vaccine in HLA A∗0201/DR1 transgenic mice: dependence on HLA class II restricted TH response L BenMohamed, R Krishnan, J Longmate, C Auge, L Low, J Primus, DJ Diamond	Human Immunology	2000
Vaccination to Treat Persistent Viral Infection MG von Herrath, DP Berger, D Homann, T Tishon, A Sette, MB Oldstone	Virology	2000
Sexually Transmitted Diseases P Vandepapelière	Sexually Transmitted Diseases	2000
Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases MC Panelli, A Riker, U Kammula, E Wang, KH Lee, SA Rosenberg, FM Marincola	Journal of immunology (Baltimore, Md. : 1950)	2000
Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100: MC Panelli, J Wunderlich, J Jeffries, E Wang, A Mixon, SA Rosenberg, FM Marincola	Journal of immunotherapy (Hagerstown, Md. : 1997)	2000
Erratum: Protection against Plasmodium falciparum malaria in chimpanzeesby immunization with the conserved pre-erythrocytic liver-stage antigen 3 P Daubersies, AW Thomas, P Millet, K Brahimi, JA Langermans, B Ollomo, L BenMohamed, B Slierendregt, W Eling, AV Belkum, G Dubreuil, JF Meis, C Guérin-Marchand, S Cayphas, J Cohen, H Gras-Masse, P Druilhe	Nature Medicine	2000
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium AH Malik, WM Lee	Annals of internal medicine	2000
The Hepatitis C Viruses CH Hagedorn, CM Rice		2000
Progress in Anti-Cancer Chemotherapy D Khayat, GN Hortobagyi		2000
Status of Cytomegalovirus Prevention and Treatment in 2000 JA Zaia, JG Sissons, S Riddell, DJ Diamond, MR Wills, AJ Carmichael, MP Weekes, M Gandhi, CL Rosa, M Villacres, S Lacey, S Markel, J Sun	Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program	2000
Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine H Gahéry-Ségard, G Pialoux, B Charmeteau, S Sermet, H Poncelet, M Raux, A Tartar, JP Lévy, H Gras-Masse, JG Guillet	Journal of virology	2000
Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization D Loirat, FA Lemonnier, ML Michel	Journal of immunology (Baltimore, Md. : 1950)	2000
A Subdominant CD8 + Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoelii Circumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture SH Kaufmann, ED Franke, A Sette, J Sacci, S Southwood, G Corradin, SL Hoffman	Infection and immunity	2000
Extension of HLA-A*0201-Restricted Minimal Epitope by Nε -Palmitoyl-lysine Increases the Life Span of Functional Presentation to Cytotoxic T Cells E Loing, M Andrieu, K Thiam, D Schörner, KH Wiesmüller, A Hosmalin, G Jung, H Gras-Masse	Journal of immunology (Baltimore, Md. : 1950)	2000
4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination JT Tan, JK Whitmire, K Murali-Krishna, R Ahmed, JD Altman, RS Mittler, A Sette, TC Pearson, CP Larsen	Journal of immunology (Baltimore, Md. : 1950)	2000
Chemoselective Acylation of Fully Deprotected Hydrazino Acetyl Peptides. Application to the Synthesis of Lipopeptides D Bonnet, N Ollivier, H Gras-Masse, O Melnyk	The Journal of Organic Chemistry	2000
Development of resistance and perspectives for future therapies against hepatitis B infections: Lessons to be learned from HIV K Deres, H Rübsamen-Waigmann	Infection	1999
Treatment of chronic hepatitis B virus infection: An Asia-Pacific perspective G Lau, W Carman, S Locarnini, K Okuda, ZM Lu, R Williams, S Lam	Journal of Gastroenterology and Hepatology	1999
Lipopeptide particles as the immunologically active component of CTL inducing vaccines I Tsunoda, A Sette, RS Fujinami, C Oseroff, J Ruppert, C Dahlberg, S Southwood, T Arrhenius, LQ Kuang, RT Kubo, RW Chesnut, GY Ishioka	Vaccine	1999
New technologies for making vaccines RW Ellis	Vaccine	1999
Structural features of a chimeric peptide inducing cytotoxic T lymphocyte responses in saline C Delmotte, EL Guern, Y Trudelle, A Delmas	European Journal of Biochemistry	1999
Solid-phase synthesis and application of double-fluorescent-labeled lipopeptides, containing a CTL-epitope from the measles fusion protein P Hoogerhout, KJ Stittelaar, HF Brugghe, JA Timmermans, GJ Hove, W Jiskoot, JH Hoekman, PJ Roholl	Journal of Peptide Research	1999
Adoptive immunotherapy prevents prostate cancer in a transgenic animal model L Granziero, S Krajewski, P Farness, L Yuan, MK Courtney, MR Jackson, PA Peterson, A Vitiello	European Journal of Immunology	1999
Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate C Klinguer, D David, M Kouach, JM Wieruszeski, A Tartar, D Marzin, JP Levy, H Gras-Masse	Vaccine	1999
Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier SK Akbar, N Horiike, M Onji	Immunology	1999
Induction of CD4+ and CD8+Bordetella pertussis Toxin Subunit S1 Specific T Cells by Immunization with Synthetic Peptides J Fagerberg, P Askelöf, H Wigzell, H Mellstedt	Cellular Immunology	1999
Update on clinical trials in the treatment of hepatitis B: HBV therapy M Pessoa, T Wright	Journal of Gastroenterology and Hepatology	1999
Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells SM Akbar, M Abe, T Masumoto, N Horiike, M Onji	Journal of Hepatology	1999
HIV and the New Viruses S McAdam, F Gotch	HIV and the New Viruses	1999
The Decade of Autoimmunity BD Stollar	The Decade of Autoimmunity	1999
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus J Heathcote, J McHutchison, S Lee, M Tong, K Benner, G Minuk, T Wright, J Fikes, B Livingston, A Sette, R Chestnut	Hepatology	1999
Antiviral Chemotherapy 5 J Mills, PA Volberding, L Corey		1999
Type 1 CD4 + T-Cell Help Is Required for Induction of Antipeptide Multispecific Cytotoxic T Lymphocytes by a Lipopeptidic Vaccine in Rhesus Macaques L Mortara, H Gras-Masse, C Rommens, A Venet, JG Guillet, I Bourgault-Villada	Journal of virology	1999
Induction of Human Papillomavirus-Specific CD4 + and CD8 + Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer AD Santin, PL Hermonat, A Ravaggi, M Chiriva-Internati, D Zhan, S Pecorelli, GP Parham, MJ Cannon	Journal of virology	1999
Prospects for the Therapeutic Use of Anticancer Vaccines: RS Chamberlain	Drugs	1999
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions P Sarobe, CD Pendleton, T Akatsuka, D Lau, VH Engelhard, SM Feinstone, JA Berzofsky	Journal of Clinical Investigation	1998
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B C Boni, A Bertoletti, A Penna, A Cavalli, M Pilli, S Urbani, P Scognamiglio, R Boehme, R Panebianco, F Fiaccadori, C Ferrari	Journal of Clinical Investigation	1998
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B HF Löhr, S Krug, W Herr, S Weyer, J Schlaak, T Wölfel, G Gerken, KH Büschenfelde	Liver	1998
Genetic Immunization of Chimpanzees Chronically Infected with the Hepatitis B Virus, Using a Recombinant Retroviral Vector Encoding the Hepatitis B Virus Core Antigen M Sällberg, J Hughes, A Javadian, G Ronlov, C Hultgren, K Townsend, CG Anderson, J O'Dea, J Alfonso, R Eason, KK Murthy, DJ Jolly, SM Chang, SJ Mento, D Milich, WT Lee	Human Gene Therapy	1998
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity SL Tsai, YM Chen, MH Chen, CY Huang, IS Sheen, CT Yeh, JH Huang, GC Kuo, YF Liaw	Gastroenterology	1998
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses ML Hedley, J Curley, R Urban	Nature Medicine	1998
Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice Y Miyahira, A García-Sastre, D Rodriguez, JR Rodriguez, K Murata, M Tsuji, P Palese, M Esteban, F Zavala, RS Nussenzweig	Proceedings of the National Academy of Sciences	1998
Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity J Alexander, MF Guercio, JD Fikes, RW Chesnut, FV Chisari, KM Chang, E Appella, A Sette	Human Immunology	1998
IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA MB Atkins	Hematology/Oncology Clinics of North America	1998
Adjuvant Is Required When Using Env Lipopeptide Construct to Induce HIV Type 1-Specific Neutralizing Antibody Responses in Mice in Vivo JP Sauzet, C Moog, A Krivine, F Martinon, M Bossus, H Gras-Masse, A Tartar, JG Guillet, E Gomard	AIDS Research and Human Retroviruses	1998
Identification of Db- and Kb-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice RG van der Most, K Murali-Krishna, JL Whitton, C Oseroff, J Alexander, S Southwood, J Sidney, RW Chesnut, A Sette, R Ahmed	Virology	1998
The optimization of helper T lymphocyte (HTL) function in vaccine development SA Kalams, BD Walker	Immunologic Research	1998
Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses C Oseroff, A Sette, P Wentworth, E Celis, A Maewal, C Dahlberg, J Fikes, RT Kubo, RW Chesnut, HM Grey, J Alexander	Vaccine	1998
The optimization of helper T lymphocyte (HTL) function in vaccine development SA Kalams, BD Walker	Immunologic Research	1998
Pharmacological Management of Chronic Viral Hepatitis NP Lam	Journal of Pharmaceutical Care in Pain & Symptom Control	1998
Immunogenicity of Four Plasmodium falciparum Preerythrocytic Antigens in Aotus lemurinus Monkeys BL Perlaza, M Arévalo-Herrera, K Brahimi, G Quintero, JC Palomino, H Gras-Masse, A Tartar, P Druilhe, S Herrera	Infection and immunity	1998
Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis R Bertoni, J Sidney, P Fowler, RW Chesnut, FV Chisari, A Sette	Journal of Clinical Investigation	1997
T cell mechanisms in the immunopathogenesis of viral hepatitis B and C S Tsai, S Huang	Journal of Gastroenterology and Hepatology	1997
Degenerate Cytotoxic T Cell Epitopes from P. falciparum Restricted by Multiple HLA-A and HLA-B Supertype Alleles DL Doolan, SL Hoffman, S Southwood, PA Wentworth, J Sidney, RW Chesnut, E Keogh, E Appella, TB Nutman, AA Lal, DM Gordon, A Oloo, A Sette	Immunity	1997
Melanoma vaccines: prospects for the treatment of melanoma P Hersey	Expert Opinion on Investigational Drugs	1997
New therapies for chronic hepatitis B JH Hoofnagle, D Lau	Journal of Viral Hepatitis	1997
Structural Properties of Chimeric Peptides Containing a T-cell Epitope Linked to a Fusion Peptide and their Importance for in Vivo Induction of Cytotoxic T-cell Responses D Lelievre, SC Hsu, P Daubos, C Favard, P Vigny, Y Trudelle, MW Steward, A Delmas	European Journal of Biochemistry	1997
Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees L Benmohamed, H Gras-Masse, A Tartar, P Daubersies, K Brahimi, M Bossus, A Thomas, P Druilhe	European Journal of Immunology	1997
Multi-epitope DNA vaccines A Suhrbier	Immunology and Cell Biology	1997
Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: Helper effect requirement for efficient primary cytotoxic T lymphocyte inductionin vitro M Ostankovitch, FA Gal, F Connan, D Chassin, J Choppin, JG Guillet	International Journal of Cancer	1997
Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance A Vitiello, A Sette, L Yuan, P Farness, S Southwood, J Sidney, RW Chesnut, HM Grey, B Livingston	European Journal of Immunology	1997
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivo MF Guercio, J Alexander, RT Kubo, T Arrhenius, A Maewal, E Appella, SL Hoffman, T Jones, D Valmori, K Sakaguchi, HM Grey, A Sette	Vaccine	1997
Prospective analysis of the factors influencing the antibody response to hepatitis b vaccine in hemodialysis patients R Peces, M la Torre, R Alcázar, JM Urra	American Journal of Kidney Diseases	1997
What is required of an HIV vaccine? CR Bangham, RE Phillips	The Lancet	1997
Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells K Kurose, SM Akbar, K Yamamoto, M Onji	Immunology	1997
Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens K Townsend, M Sällberg, J O'Dea, T Banks, D Driver, S Sauter, SM Chang, DJ Jolly, SJ Mento, DR Milich, WT Lee	Journal of virology	1997
Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope S Menne, J Maschke, TK Tolle, M Lu, M Roggendorf	Journal of virology	1997
Prospects for the development of fungal vaccines GS Deepe	Clinical microbiology reviews	1997
Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro CJ Kim, T Prevette, J Cormier, W Overwijk, M Roden, NP Restifo, SA Rosenberg, FM Marincola	Journal of immunotherapy (Hagerstown, Md. : 1997)	1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A JN Cormier, ML Salgaller, T Prevette, KC Barracchini, L Rivoltini, NP Restifo, SA Rosenberg, FM Marincola	The cancer journal from Scientific American	1997
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor α spots in response to peptide antigens W Herr, B Linn, N Leister, E Wandel, KH Büschenfelde, T Wölfel	Journal of Immunological Methods	1997
Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations T Schweighoffer	Pathology & Oncology Research	1997
Prospects for active immunotherapies for hepatitis B virus chronic carriers ML Michel	Research in Virology	1997
Peptide–MHC Complexes Assembled Following Multiple Pathways: G Corradin, S Demotz	Human Immunology	1997
Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice SM Akbar, K Kajino, K Tanimoto, K Kurose, T Masumoto, K Michitaka, N Horiike, M Onji	Journal of Hepatology	1997
Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection S Hervás-Stubbs, JJ Lasarte, P Sarobe, J Prieto, J Cullen, M Roggendorf, F Borrás-Cuesta	Journal of Hepatology	1997
Cytokines and Growth Factors in Blood Transfusion CT Sibinga, PC Das, B Löwenberg		1997
Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection DJ Diamond, J York, JY Sun, CL Wright, SJ Forman	Blood	1997
Vaccine Trials for the Clinician: Prospects for Tumor Antigens S Osanto	The oncologist	1997
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection B Rehermann, D Lau, JH Hoofnagle, FV Chisari	Journal of Clinical Investigation	1996
Treatment of Chronic Hepatitis B and Chronic Hepatitis C NA Terrault	Reviews in Medical Virology	1996
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization CE Allsopp, M Plebanski, S Gilbert, RE Sinden, S Harris, G Frankel, G Dougan, C Hioe, D Nixon, E Paoletti, G Layton, AV Hill	European Journal of Immunology	1996
Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice PA Wentworth, A Vitiello, J Sidney, E Keogh, RW Chesnut, H Grey, A Sette	European Journal of Immunology	1996
Identification of overlapping epitopes in mutantras oncogene peptides that activate CD4+ and CD8+ T cell responses SI Abrams, SF Stanziale, SD Lunin, S Zaremba, J Schlom	European Journal of Immunology	1996
Synthesis of a New Template with a Built-in Adjuvant and Its Use in Constructing Peptide Vaccine Candidates Through Polyoxime Chemistry W Zeng, DC Jackson, K Rose	Journal of Peptide Science	1996
Evaluation of hepatitis C virus protein epitopes for vaccine development R Koshy, G Inchauspé	Trends in Biotechnology	1996
Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction RE Toes, R Offringa, RJ Blom, CJ Melief, WM Kast	Proceedings of the National Academy of Sciences	1996
Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules J Sidney, HM Grey, S Southwood, E Celis, PA Wentworth, MF Guercio, RT Kubo, RW Chesnut, A Sette	Human Immunology	1996
HEPATITIS JD Bondesson, AR Saperston	Emergency Medicine Clinics of North America	1996
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs J Sidney, HM Grey, RT Kubo, A Sette	Immunology Today	1996
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity ME Ressing, R Offringa, RE Toes, F Ossendorp, JH de Jong, RM Brandt, WM Kast, CJ Melief	Immunotechnology	1996
THERAPY OF CHRONIC VIRAL HEPATITIS MW Fried	Medical Clinics of North America	1996
MHC class I-restricted CTL responses to exogenous antigens M Jondal, R Schirmbeck, J Reimann	Immunity	1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides CE Hioe, H Qiu, PD Chend, Z Bian, ML Li, J Li, M Singh, P Kuebler, P McGee, D O'Hagan, T Zamb, W Koff, C Allsopp, CY Wang, DF Nixon	Vaccine	1996
Interferon and Other Therapies for Hepatitis B and Hepatitis C Infections KD Rothstein, SJ Munoz	Clinics in Laboratory Medicine	1996
Antiviral Chemotherapy 4 J Mills, PA Volberding, L Corey		1996
Antiviral therapy of hepatitis B virus infection: Blocking viral gene expression HE Blum, F Weizsäcker, S Wieland, S Offensperger, WB Offensperger	Advanced Drug Delivery Reviews	1995
Epitope selection and development of peptide based vaccines to treat cancer E Celis, A Sette, HM Grey	Seminars in Cancer Biology	1995
Studies on in Vivo Induction of Cytotoxic T Lymphocyte Responses by Synthetic Peptides from E6 and E7 Oncoproteins of Human Papillomavirus Type 16 AK Sarkar, G Tortolero-Luna, PN Nehete, RB Arlinghaus, MF Mitchell, KJ Sastry	Viral Immunology	1995
Understanding Hepatitis B Virus Infection D Moradpour, JR Wands	New England Journal of Medicine	1995
Immunobiology of Proteins and Peptides VIII MZ Atassi, GS Bixler		1995
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules M Battegay, J Fikes, AM Bisceglie, PA Wentworth, A Sette, E Celis, WM Ching, A Grakoui, CM Rice, K Kurokohchi	Journal of virology	1995
Hepatitis B virus immunopathology FV Chisari, C Ferrari	Springer Seminars in Immunopathology	1995
Use of Helper T Cell-Inducing Peptides from Conserved Regions in HIV-1 env in a Noncovalent Mixture with a CTL-Inducing V3-Loop Peptide for in Vivo Induction of Long-Lasting Systemic CTL Response PN Nehete, RB Arlinghaus, KJ Sastry	Viral Immunology	1994
In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help ME Ressing, WJ van Driel, RM Brandt, GG Kenter, JH de Jong, T Bauknecht, GJ Fleuren, P Hoogerhout, R Offringa, A Sette, E Celis, H Grey, BJ Trimbos, WM Kast, CJ Melief	Journal of immunology (Baltimore, Md. : 1950)	1991
Viral Hepatitis R Ward, S Krugman	Disease-a-Month	1961

Advertisement